Peña, A. S., Witchel, S. F., Boivin, J., Burgert, T. S., Ee, C., Hoeger, K. M., Lujan, M. E., Mousa, A., Oberfield, S., Tay, C. T., & Teede, H. (2025). International evidence-based recommendations for polycystic ovary syndrome in adolescents. BMC Medicine, 23(1). https://doi.org/10.1186/s12916-025-03901-w

Neven, A. C. H., Forslund, M., Ranashinha, S., Mousa, A., Tay, C. T., Peña, A., Oberfield, S., Witchel, S., Teede, H., & Boyle, J. A. (2024). Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis. European Journal of Endocrinology, 191(4), S15–S27. https://doi.org/10.1093/ejendo/lvae125

Pereira-Eshraghi, C. F., & Vuguin, P. P. (2024). Polycystic Ovary Syndrome. Pediatrics in Review, 45(6), 363–365. https://doi.org/10.1542/pir.2023-006036

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., M. Redman, L., A. Boyle, J., Norman, Robert. J., Mousa, A., Joham, A. E., Arlt, W., Azziz, R., Balen, A., Bedson, L., Berry, L., Boivin, J., … Tan, K. (2023). Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 120(4), 767–793. https://doi.org/10.1016/j.fertnstert.2023.07.025

Mirza, F. G., Tahlak, M. A., Hazari, K., Khamis, A. H., & Atiomo, W. (2023). Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates. International Journal of Environmental Research and Public Health, 20(9), 5717. https://doi.org/10.3390/ijerph20095717

Violette, C. J., Agarwal, R., Mandelbaum, R. S., González, J. L., Hong, K. M., Roman, L. D., Klar, M., Wright, J. D., Paulson, R. J., Obermair, A., & Matsuo, K. (2023). The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy, 23(4), 385–395. https://doi.org/10.1080/14737140.2023.2194636

Mirza, F. G., Tahlak, M. A., Rjeili, R. B., Hazari, K., Ennab, F., Hodgman, C., Khamis, A. H., & Atiomo, W. (2022). Polycystic Ovarian Syndrome (PCOS): Does the Challenge End at Conception? International Journal of Environmental Research and Public Health, 19(22), 14914. https://doi.org/10.3390/ijerph192214914

Firestein, M. R., Romeo, R. D., Winstead, H., Goldman, D. A., Grobman, W. A., Haas, D. M., Parry, S., Reddy, U. M., Silver, R. M., Wapner, R. J., & Champagne, F. A. (2022). Hypertensive disorders during pregnancy and polycystic ovary syndrome are associated with child communication and social skills in a sex-specific and androgen-dependent manner. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.1000732

De Silva, K., Demmer, R. T., Jönsson, D., Mousa, A., Teede, H., Forbes, A., & Enticott, J. (2022). Causality of anthropometric markers associated with polycystic ovarian syndrome: Findings of a Mendelian randomization study. PLOS ONE, 17(6), e0269191. https://doi.org/10.1371/journal.pone.0269191

Harnois-Leblanc, S., Hernandez, M. I., Codner, E., Cassorla, F., Oberfield, S. E., Leibel, N. I., Mathew, R. P., Ten, S., Magoffin, D. A., Lane, C. J., Goran, M. I., Azziz, R., Baillargeon, J.-P., & Geller, D. H. (2021). Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband’s Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism, 107(3), e912–e923. https://doi.org/10.1210/clinem/dgab812